The Italian neuromodulation startup Newronika has secured a European approval for its closed-loop, adaptive implant for ...

为了解决这一问题，来自瑞典乌普萨拉大学（Uppsala University）和瑞士美敦力公司（Medtronic）等机构的研究人员 ... 研究结果显示，在 20 年的时间跨度内，深部脑刺激（deep brain stimulation，DBS）联合最佳药物治疗（best medical therapy，BMT）是最具成本效益的干预措施。

"Medtronic is the only company in the world to offer an adaptive DBS system that dynamically adjusts therapy in real time," said Brett Wall, executive vice president and president of the ...

"Medtronic is the only company in the world to offer an adaptive DBS system that dynamically adjusts therapy in real time," said Brett Wall, executive vice president and president of the Medtronic ...

Bronte-Stewart served as the global principal investigator for the Medtronic Adaptive DBS Algorithm for Personalized Therapy in Parkinson's Disease (ADAPT-PD) trial, which evaluated the safety and ...

The BrainSense Adaptive technology is an enhancement to Medtronic’s Percept DBS neurostimulators. The advancement personalizes therapy based on a patient's brain activity in real-time.

Medtronic plc, a Galway-headquartered global leader in healthcare technology, announced the US FDA has approval of BrainSense adaptive Deep Brain Stimulation (aDBS) and BrainSense Electrode Identifier ...

New closed-loop system self-adjusts DBS therapy to individual brain activity in real time; the largest commercial launch of brain-computer interface technology ever GALWAY, Ireland, Feb. 24, 2025 ...

After achieving approval for the use of deep brain stimulation for Parkinson’s in the late 1990s, Medtronic scientists ...